Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| 1 |
Visa
V
|
$833M |
| 2 |
Prudential Financial
PRU
|
$516M |
| 3 |
AGN
Allergan plc
AGN
|
$349M |
| 4 |
Medtronic
MDT
|
$280M |
| 5 |
Vornado Realty Trust
VNO
|
$257M |
Top Sells
| 1 |
Blackrock
BLK
|
$592M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$454M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$354M |
| 4 |
American Tower
AMT
|
$188M |
| 5 |
Pfizer
PFE
|
$184M |
Sector Composition
| 1 | Financials | 18.16% |
| 2 | Technology | 14.05% |
| 3 | Healthcare | 13.8% |
| 4 | Consumer Discretionary | 9.47% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Citigroup
C
$178B
| $1.28B | 0.63% | 24,789,043 +1,527,236 | +7% | +$78.7M |
|
27
Cisco
CSCO
$274B
| $1.27B | 0.62% | 46,093,249 +2,060,000 | +5% | +$56.7M |
|
28
Berkshire Hathaway Class A
BRK.A
$1.09T
| $1.25B | 0.61% | 5,751 +129 | +2% | +$28.1M |
|
29
Home Depot
HD
$405B
| $1.22B | 0.6% | 10,730,908 +190,373 | +2% | +$21.6M |
|
30
Hilton Worldwide
HLT
$64.9B
| $1.17B | 0.57% | 39,554,933 | – | – |
|
31
AT&T
T
$209B
| $1.17B | 0.57% | 35,735,759 +1,348,076 | +4% | +$44M |
|
32
Gilead Sciences
GILD
$140B
| $1.16B | 0.57% | 11,843,870 +53,104 | +0.5% | +$5.21M |
|
33
PepsiCo
PEP
$204B
| $1.16B | 0.57% | 12,111,331 +310,195 | +3% | +$29.7M |
|
|
34
Visa
V
$683B
| $1.1B | 0.54% | 16,841,532 +12,736,349 | +310% | +$833M |
|
35
CVS Health
CVS
$92.8B
| $1.05B | 0.51% | 10,129,687 +185,088 | +2% | +$19.1M |
|
36
UnitedHealth
UNH
$281B
| $998M | 0.49% | 8,437,318 +201,702 | +2% | +$23.9M |
|
37
Mastercard
MA
$538B
| $995M | 0.49% | 11,523,137 +303,681 | +3% | +$26.2M |
|
38
Amazon
AMZN
$2.44T
| $988M | 0.48% | 2,653,960 +83,084 | +3% | +$30.9M |
|
|
TFCFA
39
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $974M | 0.48% | 28,791,496 +31,671 | +0.1% | +$1.07M |
|
40
Amgen
AMGN
$155B
| $956M | 0.47% | 5,982,648 +127,338 | +2% | +$20.4M |
|
41
Qualcomm
QCOM
$173B
| $946M | 0.46% | 13,636,100 +399,843 | +3% | +$27.7M |
|
42
RTX Corp
RTX
$212B
| $931M | 0.46% | 7,942,518 -336,894 | -4% | -$39.5M |
|
|
43
Medtronic
MDT
$119B
| $888M | 0.44% | 11,386,731 +3,591,149 | +46% | +$280M |
|
|
AGN
44
DELISTED
Allergan plc
AGN
| $875M | 0.43% | 2,938,413 +1,173,244 | +66% | +$349M |
|
45
Schlumberger
SLB
$55B
| $866M | 0.42% | 10,377,745 +270,305 | +3% | +$22.6M |
|
|
46
Berkshire Hathaway Class B
BRK.B
$1.09T
| $828M | 0.41% | 5,736,901 +981,155 | +21% | +$142M |
|
47
Bristol-Myers Squibb
BMY
$96B
| $806M | 0.39% | 12,488,773 +13,152 | +0.1% | +$848K |
|
48
3M
MMM
$82.8B
| $790M | 0.39% | 4,789,765 +312,742 | +7% | +$51.6M |
|
49
Union Pacific
UNP
$133B
| $782M | 0.38% | 7,220,177 -415,655 | -5% | -$45M |
|
50
McDonald's
MCD
$224B
| $770M | 0.38% | 7,901,561 +188,379 | +2% | +$18.4M |
|